Rady Children's Institute Genomic Biorepository

Rady Children's Institute for Genomic Medicine (RCI) will collect biological samples (such as blood), derived genomic sequences (from DNA and RNA), and clinical features in a Biorepository as a standardized resource for future research studies. The purpose of the Genomic Institute Biorepository is to provide consented samples and data for basic and clinical research related to the genomic cause and treatment of childhood disease, and, in the future, as reference (Quality Control) data to improve the ability to make clinical diagnoses or clinical decisions. In addition, the Biorepository will provide a mechanism for making a diagnosis of a genetic disease. That is, once genomic sequences have been derived from biological samples, they will be immediately analyzed. If a genetic disease is identified that appears to explain an affected child's clinical features, then those results will be confirmed by the medically accepted standard, and placed in the electronic health record.

NCT Number	NCT02917460
Lead Sponsor	Rady Pediatric Genomics & Systems Medicine Institute
Conditions	Genetic Diseases
Enrollment	102,000 participants
Start Date	2016-07
Primary Completion	2050-12 (estimated)
Study Completion	2050-12 (estimated)
Updated on ClinicalTrials.gov	2022-12-12